New Delhi, Oct. 24 -- Sigachi Industries, a prominent player in the pharmaceutical excipients and active pharmaceutical ingredients (APIs) sector, has announced its financial results for the second quarter of the fiscal year 2025-26.

Sigachi reported a revenue of Rs.1,130 million for Q2 FY26, marking a 19% year-over-year decline from Rs.1,395 million in Q2 FY25. The gross profit also saw a decrease of 15.72%, amounting to Rs.397.31 million compared to Rs.471.45 million in the previous year.

The company's EBITDA stood at Rs.75 million, a substantial drop from Rs.293 million in the same quarter last year, resulting in an EBITDA margin of 6.78%, down from 21.38%. Net profit for the quarter was Rs.105 million, a 50% decrease from Rs.210 mil...